Cargando…

NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant

CMV causes mostly asymptomatic but lifelong infection. Primary infection or reactivation in immunocompromised individuals can be life-threatening. CMV viremia often occurs in solid organ transplant recipients and associates with decreased graft survival and higher mortality. Furthering understanding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pickering, Harry, Sen, Subha, Arakawa-Hoyt, Janice, Ishiyama, Kenichi, Sun, Yumeng, Parmar, Rajesh, Ahn, Richard S., Sunga, Gemalene, Llamas, Megan, Hoffmann, Alexander, Deng, Mario, Bunnapradist, Suphamai, Schaenman, Joanna M., Gjertson, David W., Rossetti, Maura, Lanier, Lewis L., Reed, Elaine F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663544/ https://www.ncbi.nlm.nih.gov/pubmed/34609965 http://dx.doi.org/10.1172/jci.insight.153175

Ejemplares similares

Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients
por: Ahn, Richard, et al.
Publicado: (2021)

638. CMV-Specific T-Cell Immune Responses in Older vs. Younger Kidney Transplant Recipients
por: Liang, Emily, et al.
Publicado: (2018)

Plasma proteome perturbation for CMV DNAemia in kidney transplantation
por: Sigdel, Tara K., et al.
Publicado: (2023)

Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor–Intolerant Patients
por: Schaenman, Joanna, et al.
Publicado: (2022)

BK Viremia Exacerbation With Adalimumab Coadministration
por: Lum, Erik L., et al.
Publicado: (2020)

629. Blood Transcriptome Variations Predict Infection and Rejection in the Older Kidney Transplant Recipient
por: Schaenman, Joanna, et al.
Publicado: (2018)

Differences in Gene Expression in Older Compared With Younger Kidney Transplant Recipients
por: Schaenman, Joanna M., et al.
Publicado: (2019)

Differences in Proinflammatory Cytokines and Monocyte Subtypes in Older as Compared With Younger Kidney Transplant Recipients
por: Liang, Emily C., et al.
Publicado: (2018)

Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients
por: Ishiyama, Kenichi, et al.
Publicado: (2022)

DNA Methylation Age Is More Closely Associated With Infection Risk Than Chronological Age in Kidney Transplant Recipients
por: Schaenman, Joanna, et al.
Publicado: (2020)

Levels of CMV Specific CD4 T Cells Are Dynamic and Correlate with CMV Viremia after Allogeneic Stem Cell Transplantation
por: Widmann, Thomas, et al.
Publicado: (2008)

940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia
por: Khawaja, Fareed, et al.
Publicado: (2021)

Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection
por: Bunnapradist, Suphamai, et al.
Publicado: (2021)

Outpatient Antimicrobial Stewardship Intervention Targeting Cytomegalovirus (CMV) Viremia in Solid Organ Transplant (SOT) Recipients
por: Wang, Nan, et al.
Publicado: (2017)

Adenovirus in a Kidney Transplant Recipient
por: Lum, Erik L., et al.
Publicado: (2023)

1752. Differential Degree and Duration of Cytomegalovirus (CMV) Viremia Between WHO International Standard-Calibrated Quantitative CMV Nucleic Acid Tests: Implications for Clinical Care
por: Meesing, Atibordee, et al.
Publicado: (2019)

CMV-Responsive CD4 T Cells Have a Stable Cytotoxic Phenotype Over the First Year Post-Transplant in Patients Without Evidence of CMV Viremia
por: Higdon, Lauren E., et al.
Publicado: (2022)

Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model
por: Olejniczak, Megan J, et al.
Publicado: (2011)

91. Differential Impact of Cytomegalovirus (CMV) Donor (D) Serostatus on Rates and Kinetics of CMV Viremia among CMV Seropositive Recipients (R+) of Ex vivo T-cell Depleted (TCD) and Unmodified (CONV) Hematopoietic Cell Transplants (HCT)
por: Stern, Anat, et al.
Publicado: (2019)

1896. A Retrospective Cohort Analysis to Determine the Incidence of CMV Viremia and Progression to CMV Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation at an Academic Children’s Hospital
por: Hayes, Molly, et al.
Publicado: (2018)

Risk Factors for CMV Viremia and Treatment-Associated Adverse Events Among Pediatric Hematopoietic Stem Cell Transplant Recipients
por: Heston, Sarah M, et al.
Publicado: (2021)

Torque teno virus viremia and QuantiFERON(®)-CMV assay in prediction of cytomegalovirus reactivation in R+ kidney transplant recipients
por: Mafi, Sarah, et al.
Publicado: (2023)

Spectrum of Coronavirus Disease 2019 Outcomes in Kidney Transplant Recipients: A Single-Center Experience
por: Lum, Erik, et al.
Publicado: (2020)

Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients
por: Gaber, A. Osama, et al.
Publicado: (2013)

Kidney Transplantation in Patients With Active Multiple Myeloma: Case Reports
por: Lum, Erik Lawrence, et al.
Publicado: (2017)

Cold Ischemia Time, Kidney Donor Profile Index, and Kidney Transplant Outcomes: A Cohort Study
por: Lum, Erik L., et al.
Publicado: (2022)

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
por: Barnes, Samantha, et al.
Publicado: (2020)

CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire
por: Hassan, Norfarazieda, et al.
Publicado: (2022)

First case of concomitant cytomegalovirus (CMV) viremia in non‐immunocompromised COVID‐19 patient and ICU management strategy in Qatar with literature review
por: Iqbal, Phool, et al.
Publicado: (2022)

Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia
por: Huang, Zhenli, et al.
Publicado: (2022)

Detailed phenotypic and functional characterization of CMV-associated adaptive NK cells in rhesus macaques
por: Hasan, Mohammad Zahidul, et al.
Publicado: (2022)

Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation
por: Park, Ki Hyun, et al.
Publicado: (2020)

1742. Kinetics of CMV Viremia with Letermovir Prophylaxis in the First 100 Days post Hematopoietic Cell Transplantation (HCT): A Single-center Experience
por: Zavras, Phaedon D, et al.
Publicado: (2019)

Deceased Donor Kidney Nonuse: A Systematic Approach to Improvement
por: Bunnapradist, Suphamai, et al.
Publicado: (2023)

NK/ILC1 cells mediate neuroinflammation and brain pathology following congenital CMV infection
por: Kveštak, Daria, et al.
Publicado: (2021)

Ly49P recognition of cytomegalovirus-infected cells expressing H2-D(k) and CMV-encoded m04 correlates with the NK cell antiviral response
por: Kielczewska, Agnieszka, et al.
Publicado: (2009)

Bocavirus viremia
por: Sukkaromdee, Pathoom, et al.
Publicado: (2015)

Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants
por: Jenkins, Meagan M., et al.
Publicado: (2023)

Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial
por: Suwelack, Barbara, et al.
Publicado: (2020)

Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies
por: Pearl, Meghan H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tir39cjl67lbmn6h02mkectnnk